Guardian Pharmacy Services’ (NYSE:GRDN – Get Free Report) lock-up period is set to expire on Tuesday, March 25th. Guardian Pharmacy Services had issued 8,000,000 shares in its public offering on September 26th. The total size of the offering was $112,000,000 based on an initial share price of $14.00. After the end of the company’s lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.
Guardian Pharmacy Services Trading Up 3.3 %
Shares of GRDN stock opened at $21.91 on Thursday. Guardian Pharmacy Services has a 1-year low of $14.16 and a 1-year high of $25.74. The stock’s fifty day simple moving average is $20.49.
Hedge Funds Weigh In On Guardian Pharmacy Services
Several institutional investors and hedge funds have recently modified their holdings of GRDN. R Squared Ltd acquired a new position in shares of Guardian Pharmacy Services during the fourth quarter valued at approximately $30,000. Investment Research & Advisory Group Inc. purchased a new position in shares of Guardian Pharmacy Services during the fourth quarter worth $34,000. BNP Paribas Financial Markets purchased a new position in shares of Guardian Pharmacy Services during the fourth quarter worth $37,000. Compass Financial Services Inc acquired a new stake in shares of Guardian Pharmacy Services in the fourth quarter valued at $58,000. Finally, JPMorgan Chase & Co. acquired a new stake in shares of Guardian Pharmacy Services in the fourth quarter valued at $77,000.
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
See Also
- Five stocks we like better than Guardian Pharmacy Services
- 3 Best Fintech Stocks for a Portfolio Boost
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Why Invest in High-Yield Dividend Stocks?
- Alphabet’s Officially In A Bear Market—Time To Buy?
- What Is WallStreetBets and What Stocks Are They Targeting?
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.